Clin Drug Invest. 2004;24(12):695-717.

Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...

"These drug manufacturers and PBMs ... to launch biosimilars of three big-selling insulin products in the US – Sanofi's Lantus, Novo Nordisk's Novolog and Eli Lilly's Humalog – by 2024.

She's been writing about credit cards and reward travel since 2011 with articles on Forbes Advisor, BoardingArea, The Points Guy and more. Her redemptio... See Full Bio Becky PokoraCredit Card ...

Robin has worked as a credit cards, editor and spokesperson for over a decade. Prior to Forbes Advisor, she also covered credit cards and related content for other national web publications ...

The attorney representing Oceanside Unified School District announced on Wednesday that it was suing three drug companies and pharmacy benefit managers for collusion in hiking up insulin costs.

Pharmacy benefit managers and prescription drug manufacturers may have artificially inflated the price of insulin, making this life-saving medication unaffordable for many Americans. Insulin ...

Boxes of the insulin injection NovoLog, made by Novo Nordisk Pharmaceutical ... alleges in its complaint that drug manufacturers and pharmacy benefit managers (PBMs) have routinely engaged ...

Metformin can interact with certain diabetes drugs, including insulin drugs and medications that help insulin better respond to the body. Diabetes medications that interact with metformin include ...